Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 145 for pancreatic cancer

Edit search filters
  1. Electron Beam Intraoperative Radiation Therapy Following Chemoradiation In Patients With Pancreatic Cancer With Vascular Involvement (PACER)

    Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate Hyperthermic Intraperitoneal Chemotherapy To Treat Patients With Pancreatic Cancer And Peritoneal Metastasis

    Rochester, MN

  3. A Study To Evaluate Binimetinib In Combination With Encorafenib In Patients With Pancreatic Malignancies And A Somatic BRAFV600E Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Claudin18.2 CAR-T (CT041) In Patients With Gastric, Pancreatic Cancer, Or Other Specified Digestive Cancers

    Rochester, MN

  6. Study Of [68Ga]FAPI-46 PET In Patients With Pancreatic Ductal Carcinoma

    Rochester, MN

  7. Phase II Study Of EUS-guided Verteporfin PDT In Solid Pancreatic Tumors

    Rochester, MN

  8. A Study To Evaluate The Diagnostic Potential Of A Lateral Flow Assay To Detect QSOX1 Peptide In Patients With Or At Risk For Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  9. Gemcitabine Hydrochloride With Or Without Erlotinib Hydrochloride Followed By The Same Chemotherapy Regimen With Or Without Radiation Therapy And Capecitabine Or Fluorouracil In Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

    Jacksonville, FL, Rochester, MN

  10. Lutetium 177Lu-Edotreotide Versus Best Standard Of Care In Well-differentiated Aggressive Grade-2 And Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE)

    Rochester, MN

.

Mayo Clinic Footer